MolNFT v1 · #44650 · protein
Solution structure of BCL-xl in its P53-bound conformation determined with selective isotope labelling of I,L,V sidechains
2ME8 · BCL-2-like protein 1: “Solution structure of BCL-xl in its P53-bound conformation determined with selective isotope labelling of…”. Solution nmr, 5 pockets (best druggability 0.68). MolNFT v1 #44650 on GenesisL1: 3D structure…
- PDB
- 2ME8
- Type
- protein
- Length
- 212 residues
- Chains
- 1
- Method
- solution nmr
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- BCL-2-like protein 1
- UniProt
- Q07817
- Pockets
- 5 · best druggability 0.68
Structure
solution nmr · 1 distinct chain · 49% helix, 0% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | BCL-2-like protein 1 | protein | 212 | 49% helix, 0% strand | Q07817 |
Pockets
5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 279 | 0.68 | 0.83 | 39 | empty |
| 2 | 52 | 0.55 | 0.90 | 14 | empty |
| 3 | 205 | 0.49 | 0.75 | 20 | empty |
| 4 | 60 | 0.45 | 0.84 | 15 | empty |
| 5 | 144 | 0.44 | 0.76 | 20 | empty |
Compared structures
- 2ME8 · Solution Structure of BCL-xL in its p53-bound conformation determined with selective… · the same entry in another collection · chain A against A, TM-score 1.00
- Q07817 · AlphaFold monomer V2.0 prediction for BCL-2-like protein 1 (Q07817) · a predicted model of the same protein · chain A against A, TM-score 0.56
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q07817
- Elsewhere: RCSB PDB 2ME8 · PDBe 2ME8 · UniProt Q07817
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.